Product NDC: | 50419-491 |
Proprietary Name: | Climara Pro |
Non Proprietary Name: | Estradiol and Levonorgestrel |
Active Ingredient(s): | 4.4; 1.39 mg/1; mg/1 & nbsp; Estradiol and Levonorgestrel |
Administration Route(s): | TRANSDERMAL |
Dosage Form(s): | PATCH |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50419-491 |
Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021258 |
Marketing Category: | NDA |
Start Marketing Date: | 20050622 |
Package NDC: | 50419-491-04 |
Package Description: | 4 PATCH in 1 CARTON (50419-491-04) |
NDC Code | 50419-491-04 |
Proprietary Name | Climara Pro |
Package Description | 4 PATCH in 1 CARTON (50419-491-04) |
Product NDC | 50419-491 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Estradiol and Levonorgestrel |
Dosage Form Name | PATCH |
Route Name | TRANSDERMAL |
Start Marketing Date | 20050622 |
Marketing Category Name | NDA |
Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
Substance Name | ESTRADIOL; LEVONORGESTREL |
Strength Number | 4.4; 1.39 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA],Inhibit Ovum Fertilization [PE],Progesterone Congeners [Chemical/Ingredient],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Progestin-containing Intrauterine Device [EPC] |